Abstract:Background: For peripheral pulmonary nodules, the regularity of lymph node (LN) metastasis has not been studied. This study aimed to evaluate the metastasis pattern of intrapulmonary and relevant mediastinal lymph nodes in early-stage lung cancer, and further selected patients who were of low risk of LN metastasis as potential population to receive sub-lobectomy. Methods: This study prospectively included consecutive patients with peripheral clinical T1N0M0 disease who underwent complete resection with LN dissection or sampling from August 2014 to July 2015. The patients were followed up to 15, May 2021. Univariable or multivariable Logistic analysis was used to identify the risk factors. Models predicting LN metastasis risk were conducted. The area under the curve for the receiver operating characteristic curves was used to evaluate the diagnostic value. Disease-free survival and overall survival were compared between groups. Results: Finally, 201 patients were included in this study. For patients with negative tumor-bearing (TB) 13 and 14 station LNs, the positive rate of other lymph node stations was extremely low. Maximum CT value, pleural indentation and CEA level were risk factors for N1 station LNs metastasis. Besides, the factors above and lobulation sign were risk factors for skip metastasis beyond TB 13 and 14 station LNs. We constructed two scoring tables to predict N1 station metastasis and skip metastasis beyond TB 13 and 14 station. The AUC were 0.837 and 0.823, respectively. Based on the first table, 40.9% of patients suffered N1 station LNs metastasis and 27.3% had N2 disease in "high risk group " while the proportion was only 5.7% and 4.5% in "low risk group ". For patients with negative TB13 and TB14 station LNs, based on the latter table, 11.1% of patients had N1 stations LNs metastasis and 16.7% had pN2 disease in "high risk group " while only 2.3% patients in "low risk group " suffered this kind of metastasis. Conclusion: For peripheral pulmonary nodules patients, stations 13 and 14 LNs may be the sentinel nodes. For patients with low risk of N1 metastasis and skip metastasis, sub-lobar resection might be sufficient for those who were of negative TB 13 and 14 station LNs.

What alters prognosis in patients who were operated for lung cancer with lymph node metastasis?

Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.

Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer

[Prognostic Analysis of N2 Non-Small Cell Lung Cancer].

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

Mediastinal lymph-nodes metastasis beyond the lobe-specific: an independent risk factor toward worse prognoses.

Mediastinal lymphadenectomy fulfilling NCCN criteria may improve the outcome of clinical N0-1 and pathological N2 non-small cell lung cancer.

Risk Analyses of N2 Lymph-Node Metastases in Patients with T1 Non-Small Cell Lung Cancer: a Multi-Center Real-World Observational Study in China

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Investigation To Metastasis Of Regional Lymph Node Station And Prediction To Long-Term Survival Following Esophagectomy In Thoracic Esophageal Cancer With Stage T1 To T3.

Preoperative Lymph Node Assessment in Surgically Resected Pathologic T1 Lung Cancer Patients: Real World Clinical Practice in China.

Lung cancer with PET/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: a multicentre study

Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment

Is the burden of metastatic lymph node stations a prognostic factor in patients with resected lung cancer?

Lymph node dissection in small-sized pulmonary metastasectomy: Impact on the long-term survival

The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study

Enlarged Mediastinal Lymph Nodes in Computed Tomography Are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes

Pathologic N0 Status in Clinical T1N0M0 Lung Adenocarcinoma is Predictable by the Solid Component Proportion with Quantitative CT Number Analysis

Prognostic Value of Lymph Node Ratio (LNR) in Patients with Postoperative N2 Feature in Non-Small Cell Lung Cancer (NSCLC)

[Investigation of Long-Term Outcome for Lung Cancer of Patients with Neoadjuvant Chemotherapy].

OA07.02 Omitting Intrapulmonary Lymph Node Retrieval May Affect the Oncological Outcome of Pn0 Lung Cancer Patients: A Propensity Score Match Analysis